Trevena Inc (TRVN)
0.4126
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.4063
-0.01
(-1.53%)
After-Hours: 05:26
Trevena Cash from Operations (Quarterly): -5.985M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.985M |
| September 30, 2023 | -8.926M |
| June 30, 2023 | -7.25M |
| March 31, 2023 | -10.87M |
| December 31, 2022 | -10.66M |
| September 30, 2022 | -10.61M |
| June 30, 2022 | -11.95M |
| March 31, 2022 | -18.26M |
| December 31, 2021 | -12.62M |
| September 30, 2021 | -11.12M |
| June 30, 2021 | -12.04M |
| March 31, 2021 | -14.41M |
| December 31, 2020 | -7.132M |
| September 30, 2020 | -2.723M |
| June 30, 2020 | -5.321M |
| March 31, 2020 | -6.218M |
| December 31, 2019 | -6.805M |
| September 30, 2019 | -6.161M |
| June 30, 2019 | -3.018M |
| March 31, 2019 | -7.683M |
| December 31, 2018 | -5.70M |
| September 30, 2018 | -3.932M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.337M |
| March 31, 2018 | -10.41M |
| December 31, 2017 | -11.81M |
| September 30, 2017 | -11.70M |
| June 30, 2017 | -18.30M |
| March 31, 2017 | -29.45M |
| December 31, 2016 | -27.69M |
| September 30, 2016 | -24.63M |
| June 30, 2016 | -18.59M |
| March 31, 2016 | -20.65M |
| December 31, 2015 | -11.85M |
| September 30, 2015 | -11.95M |
| June 30, 2015 | -10.24M |
| March 31, 2015 | -6.035M |
| December 31, 2014 | -13.05M |
| September 30, 2014 | -10.95M |
| June 30, 2014 | -9.622M |
| March 31, 2014 | -6.156M |
| December 31, 2013 | -10.55M |
| September 30, 2013 | -6.766M |
| June 30, 2013 | -4.287M |
| March 31, 2013 | -2.634M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.26M
Minimum
Mar 2022
-2.723M
Maximum
Sep 2020
-9.057M
Average
-8.926M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | 4.029M |
| Free Cash Flow | -33.08M |
| Free Cash Flow Per Share (Quarterly) | -0.3812 |
| Free Cash Flow to Equity (Quarterly) | -7.173M |
| Free Cash Flow to Firm (Quarterly) | -4.547M |
| Free Cash Flow Yield | -630.1% |